Assay Details

Gene Symbol: SERPINE1
Interrogated Sequence		Translated Protein	Exon Boundary	Assay Location	IMAGE Clone ID	Amplicon Length
RefSeq	NM_000602.5	NP_000593.1	2 - 3	416		82
	NM_001386456.1	NP_001373385.1	2 - 3	195		82
	NM_001386457.1	NP_001373386.1	2 - 3	416		82
	NM_001386458.1	NP_001373387.1	2 - 3	416		82
	NM_001386459.1	NP_001373388.1	2 - 3	416		82
	NM_001386460.1	NP_001373389.1	2 - 3	416		82
	NM_001386461.1	NP_001373390.1	2 - 3	416		82
	NM_001386462.1	NP_001373391.1	2 - 3	283		82
	NM_001386463.1	NP_001373392.1	2 - 3	409		82
	NM_001386464.1	NP_001373393.1	2 - 3	416		82
	NM_001386465.1	NP_001373394.1	2 - 3	416		82
GenBank mRNA	AK297728.1	-	3 - 4	373		82
	AK298048.1	-	2 - 3	234		82
	AK316225.1	-	3 - 4	299		82
	BC010860.1	-	2 - 3	396		82
	CN309001.1	-	2 - 3	432		82
	M14083.1	-	1 - 2	217		82
	M16006.1	-	2 - 3	349		82
	X12701.1	-	2 - 3	400		82

More Information

Updated Mapping Information

This assay targets the same location as Clariom D transcript cluster(s) TC0700008582.hg.1
This assay targets the same location as HTA transcript cluster(s) TC07000643.hg.1

Additional Information:

This assay is in the 5'UTR region of the NM_001386456.1 transcripts.

Set Membership:

Ambion siRNA available

Amplicon length between 71 and 85

Immune Tolerance Network

Mammalian Gene Collection

Homo sapiens

Human Tumor Metastasis Panel

Human LDL Pathways

Inventoried

Human_LDL

Human Tumor Metastasis

Probe spans exons

Matching Ambion siRNAs:

Click here to find siRNAs for Gene SERPINE1

Gene Ontology Categories:

Function(s) Process(es)

MicroArray Probes:

Affymetrix

Array Name	Probe IDs	Targets	Target Type
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Transcriptome Array 2.0	PSR07010027.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Transcriptome Array 2.0	PSR07010027.hg.1	ENST00000445463.2	Ensembl
Affymetrix Human Transcriptome Array 2.0	PSR07010027.hg.1	NM_000602.4	Refseq
Affymetrix Human Transcriptome Array 2.0	PSR07010027.hg.1	TC07000643.hg.1	HTA TC
Affymetrix Human Clariom D Assay	PSR0700160708.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	PSR0700160708.hg.1	NM_000602.4	Refseq
Affymetrix Human Clariom D Assay	PSR0700160708.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	PSR0700160708.hg.1	NM_000602.4	Refseq
Affymetrix Human Clariom D Assay	PSR0700160708.hg.1	TC0700008582.hg.1	Clariom D TC
Affymetrix Human Clariom D Assay	PSR0700160709.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	PSR0700160709.hg.1	NM_000602.4	Refseq
Affymetrix Human Clariom D Assay	PSR0700160709.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	PSR0700160709.hg.1	NM_000602.4	Refseq
Affymetrix Human Clariom D Assay	PSR0700160709.hg.1	TC0700008582.hg.1	Clariom D TC
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	ENST00000223095.4	Ensembl
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	NM_000602.4	Refseq
Affymetrix Human Clariom D Assay	TC0700008582.hg.1	NM_000602.4	Refseq

Citations (20)

Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma.

Authors: Purwosunu Y, Sekizawa A, Okazaki S, Farina A, Wibowo N, Nakamura M, Rizzo N, Saito H, Okai T
Journal: Am J Obstet Gynecol - Page No 3.86E+03 (Wed Apr 01 00:00:00 UTC 2009)
Volume (Year): 200 (2009)
Product Usage: -

Microarray profiling of gene expression in human adipocytes in response to anthocyanins.

Authors: Tsuda T, Ueno Y, Yoshikawa T, Kojo H, Osawa T
Journal: Biochem Pharmacol - Page No 1184 (Fri Apr 14 00:00:00 UTC 2006)
Volume (Year): 71 (2006)
Product Usage: -

Intervention in growth factor activated signaling pathways by renally targeted kinase inhibitors.

Authors: Fretz MM, Dolman ME, Lacombe M, Prakash J, Nguyen TQ, Goldschmeding R, Pato J, Storm G, Hennink WE, Kok RJ
Journal: J Control Release - Page No 200 (Thu Dec 18 00:00:00 UTC 2008)
Volume (Year): 132 (2008)
Product Usage: -

EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.

Authors: Henic E, Sixt M, Hansson S, Hoyer-Hansen G, Casslen B
Journal: Gynecol Oncol - Page No 28 (Sat Apr 01 00:00:00 UTC 2006)
Volume (Year): 101 (2006)
Product Usage: -

Comparative SAGE analysis of the response to hypoxia in human pulmonary and aortic endothelial cells.

Authors: Peters DG, Ning W, Chu TJ, Li CJ, Choi AM
Journal: Physiol Genomics - Page No 99 (Wed Jul 12 00:00:00 UTC 2006)
Volume (Year): 26 (2006)
Product Usage: -

Pattern of expression of inflammatory markers in adipose tissue of untreated hypertensive patients.

Authors: Madec S, Chiarugi M, Santini E, Rossi C, Miccoli P, Ferrannini E, Solini A
Journal: J Hypertens - Page No 1459 (Thu Jul 01 00:00:00 UTC 2010)
Volume (Year): 28 (2010)
Product Usage: -

Recurrent cytogenetic aberrations in central neurocytomas and their biological relevance.

Authors: Korshunov A, Sycheva R, Golanov A
Journal: Acta Neuropathol - Page No 303 (Thu Mar 01 00:00:00 UTC 2007)
Volume (Year): 113 (2007)
Product Usage: -

PAI-1 and functional blockade of SNAI1 in breast cancer cell migration.

Authors: Fabre-Guillevin E, Malo M, Cartier-Michaud A, Peinado H, Moreno-Bueno G, Vallee B, Lawrence DA, Palacios J, Cano A, Barlovatz-Meimon G, Charriere-Bertrand C
Journal: Breast Cancer Res - Page No R100 (Tue Jan 01 00:00:00 UTC 2008)
Volume (Year): 10 (2008)
Product Usage: -

A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions.

Authors: Kimura H, Li X, Torii K, Okada T, Takahashi N, Fujii H, Ishihara S, Yoshida H
Journal: Nephrol Dial Transplant - Page No 2496 (Fri Aug 01 00:00:00 UTC 2008)
Volume (Year): 23 (2008)
Product Usage: -

Introducing the cancer microenvironment section of Journal of Translational Medicine.

Authors: Vidal-Vanaclocha F, Witz IP
Journal: J Transl Med - Page No 60 (Fri Jan 01 00:00:00 UTC 2010)
Volume (Year): 8 (2010)
Product Usage: -

Involvement of heat shock factor 1 in statin-induced transcriptional upregulation of endothelial thrombomodulin.

Authors: Fu Q, Wang J, Boerma M, Berbee M, Qiu X, Fink LM, Hauer-Jensen M
Journal: Circ Res - Page No 369 (Fri Aug 15 00:00:00 UTC 2008)
Volume (Year): 103 (2008)
Product Usage: -

The possibility of microarray-based analysis using cell-free placental mRNA in maternal plasma.

Authors: Miura K, Miura S, Yamasaki K, Shimada T, Kinoshita A, Niikawa N, Yoshiura K, Masuzaki H
Journal: Prenat Diagn - Page No 849 (Wed Sep 01 00:00:00 UTC 2010)
Volume (Year): 30 (2010)
Product Usage: -

The -844 G/A PAI-1 polymorphism is associated with mRNA expression in rheumatoid arthritis.

Authors: Torres-Carrillo NM, Torres-Carrillo N, Vazquez-Del Mercado M, Delgado-Rizo V, Oregon-Romero E, Parra-Rojas I, Munoz-Valle JF
Journal: Rheumatol Int - Page No 355 (Fri Feb 01 00:00:00 UTC 2008)
Volume (Year): 28 (2008)
Product Usage: -

Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome.

Authors: Henry LA, Johnson DA, Sarrio D, Lee S, Quinlan PR, Crook T, Thompson AM, Reis-Filho JS, Isacke CM
Journal: Oncogene - Page No (Mon Nov 01 00:00:00 UTC 2010)
Volume (Year): (2010)
Product Usage: -

Genome-wide analysis of the endothelial transcriptome under short-term chronic hypoxia.

Authors: Ning W, Chu TJ, Li CJ, Choi AM, Peters DG
Journal: Physiol Genomics - Page No 70 (Thu Jun 17 00:00:00 UTC 2004)
Volume (Year): 18 (2004)
Product Usage: -

Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein.

Authors: Nabarro S, Himoudi N, Papanastasiou A, Gilmour K, Gibson S, Sebire N, Thrasher A, Blundell MP, Hubank M, Canderan G, Anderson J
Journal: J Exp Med - Page No 1399 (Mon Nov 21 00:00:00 UTC 2005)
Volume (Year): 202 (2005)
Product Usage: -

Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes.

Authors: Shepard AR, Millar JC, Pang IH, Jacobson N, Wang WH, Clark AF
Journal: Invest Ophthalmol Vis Sci - Page No 2067 (Thu Apr 01 00:00:00 UTC 2010)
Volume (Year): 51 (2010)
Product Usage: -

Cell-free mRNA concentrations of plasminogen activator inhibitor-1 and tissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia.

Authors: Purwosunu Y, Sekizawa A, Koide K, Farina A, Wibowo N, Wiknjosastro GH, Okazaki S, Chiba H, Okai T
Journal: Clin Chem - Page No 399 (Thu Mar 01 00:00:00 UTC 2007)
Volume (Year): 53 (2007)
Product Usage: -

Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells.

Authors: Albrektsen T, Sorensen BB, Hjorto GM, Fleckner J, Rao LV, Petersen LC
Journal: J Thromb Haemost - Page No 1588 (Wed Aug 01 00:00:00 UTC 2007)
Volume (Year): 5 (2007)
Product Usage: -

Synergistic effect of hypoxia and TNF-alpha on production of PAI-1 in human proximal renal tubular cells.

Authors: Li X, Kimura H, Hirota K, Kasuno K, Torii K, Okada T, Kurooka H, Yokota Y, Yoshida H
Journal: Kidney Int - Page No 569 (Mon Aug 01 00:00:00 UTC 2005)
Volume (Year): 68 (2005)
Product Usage: -

Availability	Inventoried
Catalog #	4331182
Price	284.00
Your Price
Online offer:	266.65

266.65
Check your price ›

System Message

Genomic Map